ACHV Financial Statements

Balance sheet, income statement, cash flow, and dividends for Achieve Life Sciences Inc (ACHV).


$121.05M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

ACHV Market Cap. (MRY)


ACHV Shares Outstanding (MRY)


ACHV Assets (MRY)


Total Assets

$38.63M

Total Liabilities

$17.73M

Total Investments

$21.65M

ACHV Income (MRY)


Revenue

$0

Net Income

-$39.83M

Operating Expense

$39.07M

ACHV Cash Flow (MRY)


CF Operations

-$29.77M

CF Investing

-$21.58M

CF Financing

$48.53M

ACHV Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ACHV Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$38,633,000 (99.44%)

$19,371,000 (-35.37%)

$29,971,000 (-36.92%)

$47,516,000 (17.91%)

Assets Current

$36,467,000 (114.74%)

$16,982,000 (-37.86%)

$27,330,000 (-38.71%)

$44,594,000 (20.61%)

Assets Non-Current

$2,166,000 (-9.33%)

$2,389,000 (-9.54%)

$2,641,000 (-9.62%)

$2,922,000 (-12.07%)

Goodwill & Intangible Assets

$2,008,000 (-10.00%)

$2,231,000 (-9.01%)

$2,452,000 (-8.34%)

$2,675,000 (-7.69%)

Shareholders Equity

$20,899,000 (1543.30%)

-$1,448,000 (-117.44%)

$8,303,000 (-70.39%)

$28,042,000 (-24.79%)

Property Plant & Equipment Net

$119,000 (80.30%)

$66,000 (0.00%)

$66,000 (3.13%)

$64,000 (-56.16%)

Cash & Equivalents

$12,753,000 (-17.97%)

$15,546,000 (-37.24%)

$24,771,000 (-42.42%)

$43,022,000 (20.00%)

Accumulated Other Comprehensive Income

$31,000 (675.00%)

$4,000 (0.00%)

$4,000 (0.00%)

$4,000 (0.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$21,646,000 (23428.26%)

$92,000 (0%)

$0 (0%)

$183,000 (0%)

Investments Current

$21,607,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$39,000 (-57.61%)

$92,000 (0%)

$0 (0%)

$183,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$111,000 (5.71%)

$105,000 (-31.37%)

$153,000 (0%)

Trade & Non-Trade Payables

$1,950,000 (215.53%)

$618,000 (-62.77%)

$1,660,000 (97.38%)

$841,000 (153.31%)

Accumulated Retained Earnings (Deficit)

-$205,578,000 (-24.03%)

-$165,751,000 (-21.93%)

-$135,936,000 (-45.25%)

-$93,586,000 (-54.86%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$9,958,000 (-40.48%)

$16,731,000 (3.29%)

$16,198,000 (8.04%)

$14,993,000 (8771.60%)

Debt Current

$55,000 (-99.67%)

$16,725,000 (3.70%)

$16,129,000 (23275.36%)

$69,000 (-25.00%)

Debt Non-Current

$9,903,000 (164950.00%)

$6,000 (-91.30%)

$69,000 (-99.54%)

$14,924,000 (19281.82%)

Total Liabilities

$17,734,000 (-14.82%)

$20,819,000 (-3.92%)

$21,668,000 (11.27%)

$19,474,000 (546.55%)

Liabilities Current

$6,682,000 (-67.90%)

$20,813,000 (-3.64%)

$21,599,000 (374.70%)

$4,550,000 (55.03%)

Liabilities Non-Current

$11,052,000 (184100.00%)

$6,000 (-91.30%)

$69,000 (-99.54%)

$14,924,000 (19281.82%)

ACHV Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$16,252,000 (42.11%)

$11,436,000 (6.66%)

$10,722,000 (17.46%)

$9,128,000 (16.01%)

Research & Development Expense

$22,817,000 (44.28%)

$15,814,000 (-47.42%)

$30,078,000 (25.50%)

$23,966,000 (248.24%)

Operating Expenses

$39,069,000 (43.37%)

$27,250,000 (-33.21%)

$40,800,000 (23.29%)

$33,094,000 (124.37%)

Interest Expense

$2,180,000 (-23.59%)

$2,853,000 (59.47%)

$1,789,000 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$39,827,000 (-33.58%)

-$29,815,000 (29.60%)

-$42,350,000 (-27.74%)

-$33,152,000 (-125.06%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$39,827,000 (-33.58%)

-$29,815,000 (29.60%)

-$42,350,000 (-27.74%)

-$33,152,000 (-125.06%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$39,827,000 (-33.58%)

-$29,815,000 (29.60%)

-$42,350,000 (-27.74%)

-$33,152,000 (-125.06%)

Weighted Average Shares

$32,071,146 (61.75%)

$19,827,354 (87.17%)

$10,593,034 (30.46%)

$8,119,836 (198.64%)

Weighted Average Shares Diluted

$32,071,146 (61.75%)

$19,827,354 (87.17%)

$10,593,034 (30.46%)

$8,119,836 (198.64%)

Earning Before Interest & Taxes (EBIT)

-$37,647,000 (-39.63%)

-$26,962,000 (33.53%)

-$40,561,000 (-22.35%)

-$33,152,000 (-125.06%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$39,069,000 (-43.37%)

-$27,250,000 (33.21%)

-$40,800,000 (-23.29%)

-$33,094,000 (-124.37%)

ACHV Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$21,580,000 (-102661.90%)

-$21,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

$48,527,000 (217.63%)

$15,278,000 (-20.82%)

$19,295,000 (-47.30%)

$36,610,000 (12.03%)

Net Cash Flow from Operations

-$29,770,000 (-21.61%)

-$24,479,000 (34.81%)

-$37,549,000 (-27.54%)

-$29,440,000 (-118.49%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$2,823,000 (69.40%)

-$9,225,000 (49.45%)

-$18,251,000 (-354.58%)

$7,169,000 (-62.64%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$21,580,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$21,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$8,295,000 (0%)

$0 (0%)

-$20,000 (-100.13%)

$14,929,000 (0%)

Issuance (Purchase) of Equity Shares

$56,936,000 (267.38%)

$15,498,000 (-19.96%)

$19,362,000 (-10.70%)

$21,681,000 (-33.75%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

-$3,000 (-200.00%)

$3,000 (400.00%)

-$1,000 (0%)

Share Based Compensation

$5,325,000 (54.84%)

$3,439,000 (5.17%)

$3,270,000 (49.52%)

$2,187,000 (70.06%)

Depreciation Amortization & Accretion

$229,000 (0.44%)

$228,000 (-3.39%)

$236,000 (-5.60%)

$250,000 (-1.96%)

ACHV Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-110.60% (88.19%)

-936.70% (-142.98%)

-385.50% (-288.61%)

-99.20% (-55.73%)

Return on Average Assets (ROAA)

-72.00% (43.62%)

-127.70% (3.26%)

-132.00% (-63.77%)

-80.60% (-38.25%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-129.20% (71.50%)

-453.30% (4.19%)

-473.10% (82.00%)

-2629.00% (-132.39%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.84 (-3.35%)

-2.75 (-348.12%)

-0.61 (67.86%)

-1.91 (-27.64%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

5.79 (109.62%)

-60.22 (-2202.02%)

2.87 (9.23%)

2.62 (233.72%)

Debt to Equity Ratio (D/E)

0.85 (105.90%)

-14.38 (-650.88%)

2.61 (276.08%)

0.69 (756.79%)

Earnings Per Share (EPS)

-1.24 (17.33%)

-1.5 (62.50%)

-4 (1.96%)

-4.08 (24.72%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.93 (24.92%)

-1.24 (65.13%)

-3.54 (2.23%)

-3.63 (26.92%)

Book Value Per Share (BVPS)

0.65 (993.15%)

-0.07 (-109.31%)

0.78 (-77.30%)

3.45 (-74.81%)

Tangible Assets Book Value Per Share (TABVPS)

1.14 (32.18%)

0.86 (-66.74%)

2.6 (-52.95%)

5.52 (-59.86%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (0.00%)

-3 (-200.00%)

-1 (0.00%)

-1 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-3.24 (-3.74%)

-3.13 (-489.81%)

-0.53 (56.77%)

-1.23 (-150.72%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

5.46 (568.75%)

0.82 (-35.49%)

1.26 (-87.09%)

9.8 (-22.20%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$29,770,000 (-21.51%)

-$24,500,000 (34.75%)

-$37,549,000 (-27.54%)

-$29,440,000 (-118.22%)

Enterprise Value (EV)

$121,353,610 (45.23%)

$83,561,931 (290.84%)

$21,380,330 (-46.98%)

$40,328,557 (469.36%)

Earnings Before Tax (EBT)

-$39,827,000 (-33.58%)

-$29,815,000 (29.60%)

-$42,350,000 (-27.74%)

-$33,152,000 (-125.06%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$37,418,000 (-39.96%)

-$26,734,000 (33.70%)

-$40,325,000 (-22.56%)

-$32,902,000 (-127.30%)

Invested Capital

$27,148,000 (1191.16%)

-$2,488,000 (6.22%)

-$2,653,000 (-121.64%)

$12,262,000 (1105.91%)

Working Capital

$29,785,000 (877.47%)

-$3,831,000 (-166.85%)

$5,731,000 (-85.69%)

$40,044,000 (17.64%)

Tangible Asset Value

$36,625,000 (113.68%)

$17,140,000 (-37.72%)

$27,519,000 (-38.63%)

$44,841,000 (19.90%)

Market Capitalization

$121,052,610 (38.82%)

$87,202,931 (266.53%)

$23,791,330 (-67.65%)

$73,548,557 (150.99%)

Average Equity

$36,004,500 (1031.15%)

$3,183,000 (-71.03%)

$10,986,500 (-67.13%)

$33,421,000 (44.55%)

Average Assets

$55,342,500 (136.96%)

$23,355,250 (-27.18%)

$32,073,250 (-22.03%)

$41,135,500 (62.88%)

Invested Capital Average

$29,130,250 (389.73%)

$5,948,250 (-30.62%)

$8,574,000 (579.94%)

$1,261,000 (794.77%)

Shares

34,389,946 (62.48%)

21,165,760 (117.96%)

9,710,747 (2.72%)

9,453,542 (161.32%)